» Articles » PMID: 21593731

Epigenetic Treatments for Cognitive Impairments

Overview
Date 2011 May 20
PMID 21593731
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Epigenetic mechanisms integrate signals from diverse intracellular transduction cascades and in turn regulate genetic readout. Accumulating evidence has revealed that these mechanisms are critical components of ongoing physiology and function in the adult nervous system, and are essential for many cognitive processes, including learning and memory. Moreover, a number of psychiatric disorders and syndromes that involve cognitive impairments are associated with altered epigenetic function. In this review, we will examine how epigenetic mechanisms contribute to cognition, consider how changes in these mechanisms may lead to cognitive impairments in a range of disorders and discuss the potential utility of therapeutic treatments that target epigenetic machinery. Finally, we will comment on a number of caveats associated with interpreting epigenetic changes and using epigenetic treatments, and suggest future directions for research in this area that will expand our understanding of the epigenetic changes underlying cognitive disorders.

Citing Articles

Advances in epigenetic treatment of adult T-cell leukemia/lymphoma: a comprehensive review.

Letafati A, Mehdigholian Chaijani R, Edalat F, Eslami N, Askari H, Askari F Clin Epigenetics. 2025; 17(1):39.

PMID: 40025589 PMC: 11871821. DOI: 10.1186/s13148-025-01841-z.


Maternal Gut Microbiome-Mediated Epigenetic Modifications in Cognitive Development and Impairments: A New Frontier for Therapeutic Innovation.

Nohesara S, Mostafavi Abdolmaleky H, Dickerson F, Pinto-Tomas A, Jeste D, Thiagalingam S Nutrients. 2025; 16(24.

PMID: 39770976 PMC: 11676351. DOI: 10.3390/nu16244355.


Mapping miRNA Research in Schizophrenia: A Scientometric Review.

Lim M, Carollo A, Neoh M, Esposito G Int J Mol Sci. 2023; 24(1).

PMID: 36613876 PMC: 9820708. DOI: 10.3390/ijms24010436.


Cognitive impairment in psychiatric diseases: Biomarkers of diagnosis, treatment, and prevention.

Wang Y, Meng W, Liu Z, An Q, Hu X Front Cell Neurosci. 2022; 16:1046692.

PMID: 36406755 PMC: 9666407. DOI: 10.3389/fncel.2022.1046692.


A qualitative analysis of factors influencing health-seeking behavior of people living with HIV, hypertension and diabetes in an urban area of Ghana.

Ali Abdulai M, Marable J, Wadus A, Asante K J Multimorb Comorb. 2022; 12:26335565221092664.

PMID: 35586035 PMC: 9106310. DOI: 10.1177/26335565221092664.


References
1.
Provost P . MicroRNAs as a molecular basis for mental retardation, Alzheimer's and prion diseases. Brain Res. 2010; 1338:58-66. PMC: 2896967. DOI: 10.1016/j.brainres.2010.03.069. View

2.
Penner M, Roth T, Barnes C, Sweatt J . An epigenetic hypothesis of aging-related cognitive dysfunction. Front Aging Neurosci. 2010; 2:9. PMC: 2874394. DOI: 10.3389/fnagi.2010.00009. View

3.
Santini E, Alcacer C, Cacciatore S, Heiman M, Herve D, Greengard P . L-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice. J Neurochem. 2009; 108(3):621-33. DOI: 10.1111/j.1471-4159.2008.05831.x. View

4.
Fischer A, Sananbenesi F, Wang X, Dobbin M, Tsai L . Recovery of learning and memory is associated with chromatin remodelling. Nature. 2007; 447(7141):178-82. DOI: 10.1038/nature05772. View

5.
Adachi M, Autry A, Covington 3rd H, Monteggia L . MeCP2-mediated transcription repression in the basolateral amygdala may underlie heightened anxiety in a mouse model of Rett syndrome. J Neurosci. 2009; 29(13):4218-27. PMC: 3005250. DOI: 10.1523/JNEUROSCI.4225-08.2009. View